Device Trial Radar · NCT04069468
Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)
Last checked: Nov 19, 2026Latest source record: Jul 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,247
Actual
Start
Mar 13, 2019
Primary completion
Dec 31, 2024
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Boston Scientific CorporationPublic (BSX)
- Sponsor type
- Industry
- Collaborators
- Biocompatibles UK Ltd
- First posted
- Aug 28, 2019
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this registry study is to gather effectiveness, QoL, safety and procedural information on TheraSphere® for the treatment of participants with Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma (iCC) and liver metastases for colon cancer (mCRC) in real world clinical practice settings in France.
Conditions
- Hepatocellular Carcinoma
Interventions
TheraSphereDevice
Participants will receive treatment with TheraSphere in accordance with Instructions for Use
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS)Time frame: Treatment (Day 1) up to participant's death, opposition to data collection, or study termination (up to Year 6)
- QoL Measurements Using FACT-HEP Questionnaire Before and After TreatmentTime frame: Treatment (Day 1), every 2 to 4 months Post Treatment (maximum treatment time = up to Day 28), and SOC visits after Month 12 until up to participant's death, opposition to data collection, study withdraw for any cause, or study termination (up to Year 6)
Locations
37 sites in 1 country. Site status is shown where the registry gives one.
CHU Amiens
Amiens, France
CHU, Angers
Angers, France
CHU Jean Minjoz
Besançon, France
34 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.